Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - BioEndeavor  
 Home
 About BioEndeavor
 Become a Member
  Join Our Network
  Research Fellows
 Training
 Projects
  BioConvergence Innovation
  Genomics
  System Biology
  Synthetic Biology
  Nanotechnology
  Environment/BioEnergy
  IAD
  Capacity Development
 Papers
 Company Case Studies
 BioInnovation News
  The BioCommons
  Emerging Market News
 Events
 Open Innovation Directory
 Biopharma Capacity Development-Emerging and BoP Markets (NEW!)
Genomics 
Systems Biology 
Synthetic Biology 
Nanotechnology 
Environment/BioEnergy 
Drug Discovery 
Health 
Technology 
Other 
 Add Organization 


Genomics
Asian Cancer Research GroupGo Back  
Organization URL

Organization:
Asian Cancer Research Group

Year Established: 2010

Profile:
Over the next two years, Lilly, Merck and Pfizer have committed to create one of the most extensive pharmacogenomic cancer databases known to date. This database will be composed of data from approximately 2,000 tissue samples from patients with lung and gastric cancer that will be made publicly available to researchers and, over time, further populated with clinical data from a longitudinal analysis of patients. Comparison of the contrasting genomic signatures of these cancers could inform new approaches to treatment.

Target Sector:
Genomics

Typology of Knowledge Network:
Open Source Community

Knowledge Type / Focus:
Data

Participant Type:
Private Sector

Objective / Knowledge Governance:
Cooperative Research

IP Management:
Open Access.


2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles